Skip to content

Dyadic Interventions to Boost Quality of Life Among Stroke Survivors and Care Partners in Pakistan.

Augmented Dyadic Interventions to Boost Quality of Life Among Stroke Survivors and Care Partners in Pakistan.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06827093
Enrollment
392
Registered
2025-02-14
Start date
2021-10-01
Completion date
2024-12-01
Last updated
2025-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke

Keywords

Stroke survivor, Dyadic intervention

Brief summary

This study (RCTs) will be conducted on stroke survivors and their care partners after discharge from the hospital. The study will aim to evaluate the impact of augmented dyadic intervention on the quality of life of stroke survivors and caregiver burden. A randomized control trial with a parallel group design will be used for the study. The design used for the current study will be single-blind, randomized controlled trials with repeated measures. Each group will include 196 subjects (98 stroke survivors and 98 care partners). The total number of individuals will be 392, including 196 stroke survivors and 196 care partners. Stroke survivors will have an age range of 18-75 years and both genders with a confirmed diagnosis of stroke. The goal of this study will be to rehabilitate patients with disability, there is a dire need for dyad interventions to support and train stroke care partners by providing education, counselling, emotional support and access to health services. The hypothesis of this (RCTs )is that there is no relationship between stress and quality of life for improvement in quality of life through dyadic intervention.

Detailed description

Stroke is a leading cause of mortality and disability around the world, leaving survivors with significant physical deficits and resulting in a variety of psychological problems as well as social constraints and retreats for both the survivors and their families. The study population will be stroke survivors and their care partners after discharge from the hospital. The design will be single-blind, randomized controlled trials with repeated measures. A total of 392 participants will be recruited voluntarily, of which 196 will be randomly assigned to the control group and 196 to the intervention group. A five-session intervention containing three face-to-face and two telephonic sessions will be delivered. A valid and reliable stroke-specific quality of life questionnaire for stroke survivors and Zarit Burden and an interview for caregiver burden will be used. The primary investigator will train two qualified nurses in each province for 2 weeks to deliver interventions to promote fairness. Permission will be obtained from the tertiary care hospital to check the medical records for the study population and to contact them based on their medical records after 2 weeks of discharge. First, the patients will be contacted by telephone for inclusion criteria based on their records and being voluntary participants in the study, and then pretest data will be collected. The experimental group will receive five sessions, while the control group will receive routine care. The first post-test will be conducted three months after the intervention, the second post-test will be conducted six months later, and the third post-test will be conducted 12 months later Data analysis will be performed through SPSS 22 as descriptive (frequency and percentages for categorical variables, while the mean and standard deviation for continuous variables) and inferential statistics (independent t-test for differences between the groups and Pearson correlation for association with demographic variables).

Interventions

OTHERSkill Building Dyadic Intervention

The focal point of skill-building interventions contains some strategies that facilitate problem-solving, goal setting, communicating with care experts, stress management, hands-on training in such skills (lifting and mobility techniques and assistance with activities of daily living), and modification of communication according to the needs of stroke survivors.

Sponsors

Zhengzhou University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

single-blind, randomized controlled trials with repeated measures, The primary investigator trained two qualified nurses in each province continuously for 2 weeks to deliver interventions to promote fairness. Permission was obtained from the tertiary care hospital to check the medical records of the study population and to contact them based on their medical records after 2 weeks of discharge. First, the patients were contacted by telephone for inclusion criteria based on their records and being voluntary participants in the study, and then pretest data was collected. The experimental group were received five sessions, while the control group ere received only routine care. The first post-test was conducted three months after the intervention, the second post-test was conducted six months later, and the third post-test was conducted 12 months later.

Intervention model description

single-blind, randomized controlled trials with repeated measures

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* The study includes stroke survivors: * Having an age range of 18-75 years with a confirmed diagnosis of stroke (confirmed by a neurologist with radiological evidence by either CT scan and/or MRI) and meeting the following eligibility criteria was required. 26 * Having a diagnosis of stroke More than 15 days * Stable, non-fluctuating stroke with no acute, ongoing neurological * No preexisting disability before stroke (defined by mRS =0). * Independent in daily living activities before the stroke * Expected to return home with residual disability While the inclusion criteria for care partners was an identified primary care partner greater than 18 years of age, 1. Able to speak 2. Urdu speaker 3. Care partners include aphasic patients and demented patients. 4. No significant physical or psychological disability 5. Be willing and able to provide support to patients after discharge

Design outcomes

Primary

MeasureTime frameDescription
promoting the quality of life and care of stroke patients12 months of interventionThis study will evaluate the effects of a skill-building dyadic intervention on improving the quality of life (QOL) for 392 individuals, consisting of 196 stroke survivors and their 196 care partners. The study will utilize a 49-item stroke-specific questionnaire to assess the quality of life of stroke survivors across 12 domains. This comprehensive tool will provide valuable insights into the various aspects of stroke survivors' lives. The study's outcome is expected to reveal significant improvements in the quality of life of stroke survivors. After receiving the intervention, participants will report enhanced knowledge, satisfaction, and self-efficacy. Specifically, the study will find positive impacts on energy, mobility, mood, and treatment efficacy, ultimately leading to an improved quality of life for stroke survivors.

Secondary

MeasureTime frameDescription
Reduces the burden of dyad members12 monthsThe Zarit Burden Interview (ZBI) will assess caregiver burden using a modified 22-item scale. This scale will feature a 5-point Likert scale (0-4) across four domains: confidence, competence, quality of care, and self-efficacy. Data analysis will utilize Pearson correlation through SPSS 26.0 to explore the relationship between stroke survivors and caregiver burden with demographic variables. This study aims to reduce stroke survivors' and caregivers' psychological, social, and financial burdens. A single-blind, randomized controlled trial with 392 participants (196 stroke survivors, 196 care partners) will test a 5-session intervention, with data collection at pre-intervention, and post-intervention (3, 6, 12 months).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026